SCHEMBL3244276

SCHEMBL3244276

FC(F)(F)c1cc([B-](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(C(F)(F)F)c1.c1ccc([S+](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KIF11 P52732 2/20 0.41
P2RX1 P51575 1/20 0.37
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
TACR1 P25103 7/20 0.36
MAPK1 P28482 1/20 0.34
NPBWR1 P48145 1/20 0.34
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
SCN2A Q99250 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
METAP2 P50579 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3144568 0.95 KIF11 (0.46) TSHRALDH1A1KIF11P2RX1IDO1
SCHEMBL3139294 0.95 KIF11 (0.46) TSHRALDH1A1KIF11P2RX1IDO1
SCHEMBL6513245 0.93 TSHR (0.41) TSHRALDH1A1KIF11P2RX1IDO1
SCHEMBL3137155 0.92 TDP1 (0.36) TSHRALDH1A1KIF11P2RX1IDO1
SCHEMBL3130049 0.92 TDP1 (0.36) TSHRALDH1A1KIF11P2RX1IDO1
SCHEMBL3134861 0.91 CYP19A1 (0.35) TSHRALDH1A1KIF11MAPTHTT
SCHEMBL3130596 0.91 KIF11 (0.37) TSHRALDH1A1KIF11P2RX1TACR1
SCHEMBL3139818 0.91 NFE2L2 (0.39) TSHRALDH1A1KIF11P2RX1IDO1
SCHEMBL3134845 0.91 CYP19A1 (0.35) TSHRALDH1A1KIF11MAPTHTT
SCHEMBL3132670 0.91 NFE2L2 (0.39) TSHRALDH1A1KIF11P2RX1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583740-B1 FLUOROARYLSULFONIUM PHOTOACID GENERATORS STX APRILIS INC (US) 2010-05-26 EP disclosed
US-20090182172-A1 Fluoroarylsulfonium photoacid generators STX APRILIS, INC. 2009-07-16 US disclosed
EP-1583740-A2 FLUOROARYLSULFONIUM PHOTOACID GENERATORS Aprilis, Inc. (US) 2005-10-12 EP disclosed
US-20050059543-A1 Fluoroarylsulfonium photoacid generators APRILIS (US) 2005-03-17 US disclosed
WO-2004058699-A2 FLUOROARYLSULFONIUM PHOTOACID GENERATORS APRILIS, INC. (US) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090182172-A1 Fluoroarylsulfonium photoacid generators PFAS, PAG1, TST TSHR 3755/4885ALDH1A1 1301/4885KIF11 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.